Articles by Michelle Hoffman - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

  • Search
  • Suppliers
  • Careers

Enter a company or product name

Keyword Location
About Search
Articles by Michelle Hoffman

Coming Down the Pike: hES cells

Jan 2, 2008

The most significant early-stage discovery to hit the journals in late 2007 were the dual announcements from two independent research groups that they turned adult human skin cells into cells with properties that are seemingly identical with human embryonic stem (hES) cells.

30 Years Hence: It Won't Be Your Parents' Pharmaceutical Industry

Dec 2, 2007

"May you live in interesting times," goes the allegedly ancient Chinese curse. Well, these have been "interesting times" indeed for those working in the pharmaceutical industry.

Here's to Innovation

Dec 2, 2007

Drug makers, drug inspectors, and drug consumers need to demand that new drugs be effective.

Sanofi-Aventis to Build Vaccine Facility in China

Nov 29, 2007

Sanofi-aventis entered into an agreement with Chinese authorities allowing Sanofi to construct a vaccine-manufacturing plant in Shenzhen municipality.

Programming a Seamless Supply Chain

Information technology is the glue that should unify a company while ironically, it enables further fragmentation. Experts talk about the successes and challenges for IT in helping a company function efficiently.
Nov 2, 2007

Information technology is the glue that should unify a company while ironically, it enables further fragmentation. Experts talk about the successes and challenges for IT in helping a company function efficiently.

What Good is Winning a Prize if No One Cares?

Thanks to the media, Nobel Laureates are underrated, undervalued, and simply uncool.
Nov 2, 2007

Thanks to the media, Nobel Laureates are underrated, undervalued, and simply uncool.

Tech Talk: A Q&A with Oracle's Arvindh Balakrishnan

The senior director of Oracle's Life Sciences Business Unit tackles some of the technical issues regarding regulatory standardization, software integration, and the trend toward virtualization, among other things.

Do you have something to ask Arvindh Balakrishnan? Click here to submit your questions.


Nov 1, 2007

The senior director of Oracle's Life Sciences Business Unit tackles some of the technical issues regarding regulatory standardization, software integration, and the trend toward virtualization, among other things.

Do you have something to ask Arvindh Balakrishnan? Click here to submit your questions.

Novartis Expands Operations in Singapore

Nov 1, 2007

Novartis opened a new $180-million tableting facility in late October in Singapore and announced its intention to construct a $700-million cell-culture facility in the country.

Who's in Charge?

Courts are denying the terminally ill access to experimental drugs, leaving many with no options.
Oct 2, 2007

Courts are denying the terminally ill access to experimental drugs, leaving many with no options.

ADVERTISEMENT

LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
FDASIA was signed into law two years ago. Where has the most progress been made in implementation?
Reducing drug shortages
Breakthrough designations
Protecting the supply chain
Expedited reviews of drug submissions
More stakeholder involvement
Reducing drug shortages
70%
Breakthrough designations
4%
Protecting the supply chain
17%
Expedited reviews of drug submissions
2%
More stakeholder involvement
7%
View Results
Eric Langerr Outsourcing Outlook Eric LangerTargeting Different Off-Shore Destinations
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerAsymmetric Synthesis Continues to Advance
Jill Wechsler Regulatory Watch Jill Wechsler Data Integrity Key to GMP Compliance
Sean Milmo European Regulatory WatchSean MilmoExtending the Scope of Pharmacovigilance Comes at a Price
FindPharma Custom Search
Click here